Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jul 31, 2025 | (FY)Jul 31, 2024 | (FY)Jul 31, 2023 | (FY)Jul 31, 2022 | |
|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||
| Cash from operating activities | -619.96%-1.97B | 58.89%-273.03M | -36.70%-664.2M | -485.9M |
| Net profit before non-cash adjustment | 110.81%46.98M | 31.99%-434.73M | -40.26%-639.21M | ---455.74M |
| Total adjustment of non-cash items | -2,268.27%-1.6B | 7.96%73.62M | 486.36%68.19M | --11.63M |
| -Depreciation and amortization | -26.38%47.24M | -3.19%64.16M | 294.57%66.27M | --16.8M |
| -Reversal of impairment losses recognized in profit and loss | ---- | --0 | --3.34M | --0 |
| -Share of associates | ---30.15M | ---- | ---- | ---- |
| -Disposal profit | --0 | ---- | ---- | ---- |
| -Other non-cash items | -17,149.93%-1.61B | 765.94%9.46M | 72.49%-1.42M | ---5.17M |
| Changes in working capital | -572.74%-416.35M | 194.51%88.07M | -122.97%-93.19M | ---41.79M |
| -Change in receivables | -295.76%-322.28M | -3,547.63%-81.43M | 114.81%2.36M | ---15.94M |
| -Change in inventory | -306.91%-51.85M | 128.02%25.06M | -166.78%-89.43M | ---33.52M |
| -Change in prepaid assets | -466.38%-17.64M | -29.65%4.82M | 128.75%6.84M | ---23.8M |
| -Change in payables | -174.86%-44.73M | 1,600.18%59.75M | -127.09%-3.98M | --14.7M |
| -Change in accrued expense | 90.46%40.2M | 139.73%21.11M | -31.78%8.8M | --12.91M |
| -Changes in other current assets | -164.49%-23.7M | 335.29%36.75M | -657.59%-15.62M | --2.8M |
| -Changes in other current liabilities | -83.42%3.65M | 1,116.43%22.03M | -303.47%-2.17M | --1.07M |
| Dividends paid (cash flow from operating activities) | ||||
| Dividends received (cash flow from operating activities) | ||||
| Interest paid (cash flow from operating activities) | -81.02%-11.17M | -79.80%-6.17M | -1,495.81%-3.43M | -215K |
| Interest received (cash flow from operating activities) | 12,775.00%515K | 100.00%4K | 0.00%2K | 2K |
| Tax refund paid | -70.53%-3.24M | -462.13%-1.9M | -119.93%-338K | 1.7M |
| Other operating cash inflow (outflow) | 5,725.69%1.62B | -7.52%27.74M | 120.10%30M | 13.63M |
| Operating cash flow | -43.41%-363.33M | 60.29%-253.35M | -35.51%-637.97M | ---470.78M |
| Investing cash flow | ||||
| Net PPE purchase and sale | -501.17%-40.99M | 96.36%-6.82M | -184.22%-187.06M | ---65.81M |
| Net intangibles purchase and sale | 63.68%-850K | -204.29%-2.34M | 84.46%-769K | ---4.95M |
| Net changes in other investments | ---19.52M | ---- | ---- | ---6.58M |
| Investing cash flow | -569.95%-61.35M | 95.12%-9.16M | -142.85%-187.83M | ---77.34M |
| Financing cash flow | ||||
| Net issuance payments of debt | 889.18%122.48M | -108.27%-15.52M | 136.35%187.73M | --79.43M |
| Net common stock issuance | -100.02%-162K | -18.60%730.6M | 72.22%897.55M | --521.15M |
| Net other fund-raising expenses | ---1K | ---- | ---- | --1K |
| Financing cash flow | -82.89%122.32M | -34.11%715.08M | 80.70%1.09B | --600.59M |
| Net cash flow | ||||
| Beginning cash position | 74.35%1.06B | 74.31%608.67M | 17.68%349.18M | --296.72M |
| Current changes in cash | -166.81%-302.37M | 74.41%452.57M | 394.65%259.49M | --52.46M |
| Effect of exchange rate changes | ---6.89M | ---- | ---- | ---- |
| Cash adjustments other than cash changes | ---- | 0.00%-1K | ---1K | ---- |
| End cash Position | -29.14%751.99M | 74.35%1.06B | 74.31%608.67M | --349.18M |
| Free cash flow | -56.95%-412.02M | 68.21%-262.51M | -52.49%-825.79M | ---541.55M |
| Currency Unit | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |